Enhanced PET Imaging Radiotracers Designed for Better Tracking of Disease
By MedImaging International staff writers Posted on 09 Jun 2014 |
Scientists have developed a direct approach for making single enantiomer positron emission tomography (PET) tracers.
Small molecules containing a radioactive isotope of fluorine called 18F radiotracers are used to detect and track specific diseases in patients. When injected into the body, these molecules collect in specific targets, such as tumors, and can be visualized by their radioactive tag on a PET imaging scan. The 18F tags rapidly decay, therefore, no radioactivity remains after approximately one day.
But there are only a few strategies available for making 18F radiotracers. Furthermore, existing techniques tend to require harsh conditions that jumble the placement of a radiotracer’s more delicate chemical bonds. Researchers at Princeton University (Princeton, NJ, USA) reported that they now have a way to produce 18F radiotracers that avoids that problem. “It’s the first method to do enantio-selective carbon-18F bond formation,” said lead investigator Dr. Abigail Doyle, a Princeton associate professor of chemistry.
Radiotracers up to now have mostly been evaluated as mixtures of enantiomers. Enantiomers are molecules that are totally identical in composition but the arrangement of atoms at the chiral center are mirror images. A chiral center is an atom, typically carbon, which is connected to four different groups. “We know in biology, small molecule interactions with enzymes often depend on the 3D [three-dimensional] properties of the molecule. Being able to prepare the enantiomers of a given chiral tracer, in order to optimize which tracer has the best binding and imaging properties could be really useful,” Dr. Doyle said.
The researchers developed a cobalt fluoride catalyst—[18F](salen)CoF—to install the radioactive fluoride through the ring-opening reaction of epoxides. Their approach demonstrated excellent enantioselectivity for 11 substrates, five of which are known pre-clinical PET tracers. With this new method, researchers can now assess single enantiomers of existing or new PET radiotracers and evaluate if these compounds offer any benefits over the enantiomeric combinations. Eventually, the goal is to use this chemistry to identify a completely new PET radiotracer for imaging.
Currently, there are only four US Food and Drug Administration (FDA)-approved 18F radiotracers. One of the major limitations to discovering PET tracers is the fact that the only commercially available source of 18F is nucleophilic fluoride. Existing 18F sources are very basic, and during the process of making the 18F radiotracer, can cause the elimination of alcohol and amine groups and rearrange the groups around a chiral center in a process called racemization. Under Dr. Doyle’s less basic reaction conditions, even alcohols and secondary amines are tolerated and no racemization is seen.
“Forming carbon-fluorine bonds by nucleophilic fluoride is challenging. One typically needs to use high temperatures or else the reactions are too slow to permit radioisotope incorporation,” Dr. Doyle commented. “Whereas most reactions require temperatures greater than 100° Celsius, our reaction can be run at 50° Celsius.”
Small amounts of radioactivity were sufficient to develop the reaction at first but to perform imaging studies, larger amounts of radioactivity are necessary. “When you go to higher activity, that’s when you do automated chemistry in a hot cell, which is basically a block of lead so you get no exposure,” Dr. Doyle said.
To be efficient in an industrial environment, the chemistry needs to be converted from the laboratory to an automated hot cell. The researchers were given access to an automated hot cell nearby at Merck’s West Point (PA, USA) site. The whole process of radiolabeling takes about 30 to 45 minutes when it is automated. The set-up includes a robotic arm that delivers solutions to designated vials, a high-performance liquid chromatography (HPLC) system and a rotary evaporator, which are devices for the analysis and purification of the radiotracers.
“The catalyst is very robust and the fact that we can translate the reaction directly to the hot cell bodes very well for non-experts to be able to run these sorts of reactions,” Dr. Doyle concluded. “We demonstrated that the radioactivity is high enough that we could actually use it for imaging. That’s an exciting next step.”
Related Links:
Princeton University
Small molecules containing a radioactive isotope of fluorine called 18F radiotracers are used to detect and track specific diseases in patients. When injected into the body, these molecules collect in specific targets, such as tumors, and can be visualized by their radioactive tag on a PET imaging scan. The 18F tags rapidly decay, therefore, no radioactivity remains after approximately one day.
But there are only a few strategies available for making 18F radiotracers. Furthermore, existing techniques tend to require harsh conditions that jumble the placement of a radiotracer’s more delicate chemical bonds. Researchers at Princeton University (Princeton, NJ, USA) reported that they now have a way to produce 18F radiotracers that avoids that problem. “It’s the first method to do enantio-selective carbon-18F bond formation,” said lead investigator Dr. Abigail Doyle, a Princeton associate professor of chemistry.
Radiotracers up to now have mostly been evaluated as mixtures of enantiomers. Enantiomers are molecules that are totally identical in composition but the arrangement of atoms at the chiral center are mirror images. A chiral center is an atom, typically carbon, which is connected to four different groups. “We know in biology, small molecule interactions with enzymes often depend on the 3D [three-dimensional] properties of the molecule. Being able to prepare the enantiomers of a given chiral tracer, in order to optimize which tracer has the best binding and imaging properties could be really useful,” Dr. Doyle said.
The researchers developed a cobalt fluoride catalyst—[18F](salen)CoF—to install the radioactive fluoride through the ring-opening reaction of epoxides. Their approach demonstrated excellent enantioselectivity for 11 substrates, five of which are known pre-clinical PET tracers. With this new method, researchers can now assess single enantiomers of existing or new PET radiotracers and evaluate if these compounds offer any benefits over the enantiomeric combinations. Eventually, the goal is to use this chemistry to identify a completely new PET radiotracer for imaging.
Currently, there are only four US Food and Drug Administration (FDA)-approved 18F radiotracers. One of the major limitations to discovering PET tracers is the fact that the only commercially available source of 18F is nucleophilic fluoride. Existing 18F sources are very basic, and during the process of making the 18F radiotracer, can cause the elimination of alcohol and amine groups and rearrange the groups around a chiral center in a process called racemization. Under Dr. Doyle’s less basic reaction conditions, even alcohols and secondary amines are tolerated and no racemization is seen.
“Forming carbon-fluorine bonds by nucleophilic fluoride is challenging. One typically needs to use high temperatures or else the reactions are too slow to permit radioisotope incorporation,” Dr. Doyle commented. “Whereas most reactions require temperatures greater than 100° Celsius, our reaction can be run at 50° Celsius.”
Small amounts of radioactivity were sufficient to develop the reaction at first but to perform imaging studies, larger amounts of radioactivity are necessary. “When you go to higher activity, that’s when you do automated chemistry in a hot cell, which is basically a block of lead so you get no exposure,” Dr. Doyle said.
To be efficient in an industrial environment, the chemistry needs to be converted from the laboratory to an automated hot cell. The researchers were given access to an automated hot cell nearby at Merck’s West Point (PA, USA) site. The whole process of radiolabeling takes about 30 to 45 minutes when it is automated. The set-up includes a robotic arm that delivers solutions to designated vials, a high-performance liquid chromatography (HPLC) system and a rotary evaporator, which are devices for the analysis and purification of the radiotracers.
“The catalyst is very robust and the fact that we can translate the reaction directly to the hot cell bodes very well for non-experts to be able to run these sorts of reactions,” Dr. Doyle concluded. “We demonstrated that the radioactivity is high enough that we could actually use it for imaging. That’s an exciting next step.”
Related Links:
Princeton University
Latest Nuclear Medicine News
- Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
- New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
- Combining Advanced Imaging Technologies Offers Breakthrough in Glioblastoma Treatment
- New Molecular Imaging Agent Accurately Identifies Crucial Cancer Biomarker
- New Scans Light Up Aggressive Tumors for Better Treatment
- AI Stroke Brain Scan Readings Twice as Accurate as Current Method
- AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer
Channels
Radiography
view channel
AI Detects Fatty Liver Disease from Chest X-Rays
Fatty liver disease, which results from excess fat accumulation in the liver, is believed to impact approximately one in four individuals globally. If not addressed in time, it can progress to severe conditions... Read more
AI Detects Hidden Heart Disease in Existing CT Chest Scans
Coronary artery calcium (CAC) is a major indicator of cardiovascular risk, but its assessment typically requires a specialized “gated” CT scan that synchronizes with the heartbeat. In contrast, most chest... Read moreMRI
view channel
AI Model Outperforms Doctors at Identifying Patients Most At-Risk of Cardiac Arrest
Hypertrophic cardiomyopathy is one of the most common inherited heart conditions and a leading cause of sudden cardiac death in young individuals and athletes. While many patients live normal lives, some... Read more
New MRI Technique Reveals Hidden Heart Issues
Traditional exercise stress tests conducted within an MRI machine require patients to lie flat, a position that artificially improves heart function by increasing stroke volume due to gravity-driven blood... Read moreUltrasound
view channel
Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery
Chronic pain affects millions of people globally, often leading to long-term disability and dependence on opioid medications, which carry significant risks of side effects and addiction.... Read more
New Medical Ultrasound Imaging Technique Enables ICU Bedside Monitoring
Ultrasound computed tomography (USCT) presents a safer alternative to imaging techniques like X-ray computed tomography (commonly known as CT or “CAT” scans) because it does not produce ionizing radiation.... Read moreGeneral/Advanced Imaging
view channel
CT Colonography Beats Stool DNA Testing for Colon Cancer Screening
As colorectal cancer remains the second leading cause of cancer-related deaths worldwide, early detection through screening is vital to reduce advanced-stage treatments and associated costs.... Read more
First-Of-Its-Kind Wearable Device Offers Revolutionary Alternative to CT Scans
Currently, patients with conditions such as heart failure, pneumonia, or respiratory distress often require multiple imaging procedures that are intermittent, disruptive, and involve high levels of radiation.... Read more
AI-Based CT Scan Analysis Predicts Early-Stage Kidney Damage Due to Cancer Treatments
Radioligand therapy, a form of targeted nuclear medicine, has recently gained attention for its potential in treating specific types of tumors. However, one of the potential side effects of this therapy... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more